about
Quality markers in cardiology: measures of outcomes and clinical practice--a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular SurgeryTakotsubo Syndrome: A Pathway through the Pituitary Disease.Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementationEffort syncope and pencil-point left main coronary artery: cause or unsual finding?Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies.The value of intravascular ultrasound in interventional cardiology.Abnormal right heart filling after cardiac surgery: time course and mechanisms.American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert ConsenThird universal definition of myocardial infarction.Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis.Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis.The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies.How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis.Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants: Systematic Review and Meta-analysis.Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis.Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.When and how to diagnose patent foramen ovale.Therapeutic angiogenesis induced by human umbilical cord tissue-derived mesenchymal stromal cells in a murine model of hindlimb ischemia.Coronary Fistulas in a Patient with a Novel Long QT Syndrome Mutation.[Intracoronary echocardiography: current perspectives]Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis.Longitudinal Impact of the Smoking Ban Legislation in Acute Coronary Syndrome Admissions.Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures.Non-compaction cardiomyopathy.Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis.The vulnerable plaque: current concepts and future perspectives on coronary morphology, composition and wall stress imaging.Appropriateness criteria for cardiovascular imaging use in clinical practice: a position statement of the ESC/EACVI taskforce.Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugs.Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging.The current and future status of nuclear cardiology: a consensus report.Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis.Non-compaction cardiomyopathy: prevalence, prognosis, pathoetiology, genetics, and risk of cardioembolism.Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients.Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis.Barriers to cardiovascular device innovation in Europe.Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis.
P50
Q26778567-E4309F6A-4F1A-421F-BB2F-D155BEDB1309Q27348873-A7FD92EE-3192-4ACF-A0DD-19E429F78E97Q27690881-E5AB019C-C56F-4E96-AF0E-315C4CF73764Q28087146-CAD52AD2-339B-43F2-9B7E-480D04A573A1Q33165779-EF5112AA-9CE7-413D-97EF-40B2D1BB2A3CQ33275809-7ADE4288-392E-4ABB-8D70-EB15D8D25515Q33587259-3586A6F3-7728-4314-9148-D79EB38E48CCQ33611841-AA2D5FB0-11FA-429B-9B0B-C76F440D0728Q34217539-49730CC0-2C48-40CD-AEFE-509A956DA20CQ34295914-E66D7685-1EC1-470E-A804-49E69AC6FEA2Q35205072-45756B7A-7F0F-47CD-9818-1925339D4665Q35224171-F01C0DEB-0CD0-42DD-9A48-C84F6849641CQ35266904-FAB66CC3-448B-48B0-BBA2-2D1B766B774FQ35471278-C0CCBA21-74ED-4F10-8CA6-A9CBA76740D5Q35553820-FC5597EC-DAEF-4F2B-BBEF-EB770E7C638BQ35624075-477B2A30-DFDC-4214-BAB0-FC9AE7001395Q35640960-377311E0-6639-49FA-9F82-5588B4A314F0Q35650348-5EC5E229-AFF6-41A3-BCCD-40C2B99D80FEQ36021472-9DB00D91-1B69-4FEB-B212-A884BF767708Q36072658-C7FC6278-C372-4E4B-A5F8-259EA33970A9Q36146690-17FFFED6-255B-4348-95A9-5A0F76B8279FQ36295818-79550B1E-A3E5-4705-9205-C51DFD554D9DQ36705697-F05B9C60-7442-4E25-A901-7CDC15D6C702Q37628295-ED2BBD91-AF02-40AB-BA1B-24E87AEDA510Q37654410-8CA80375-162A-4AF7-9EC8-F085AB8BAEEBQ38015242-07E6E3FE-C2FE-4EF6-BC6F-05066DD3E806Q38090424-883F7911-6702-4C7B-81BE-8E6667FE5E47Q38183208-614DA5CA-7F72-4169-8FB3-4592B5A4D958Q38186864-CD26C288-7885-4933-A3D2-D1B3A1B7101EQ38196795-A0EA612E-F013-4800-9908-889814D74B3FQ38198567-792755C0-52D7-48A2-BE52-AC9E443BB0ABQ38198875-EDBCE9A9-78D0-4616-BF36-E1AAA7BFF9F9Q38211234-1F75E892-CC51-4D90-A663-B204E6D6705AQ38225415-8A77F279-558C-4531-9FB7-AC10D58E5059Q38252732-B5D3E2DC-43B9-4D56-AA41-796412DC026BQ38256763-76BD582B-E7F9-4AA3-A1DC-B937D5C9C99EQ38532303-68AFA7ED-0F17-459C-86EB-F969079D66B2Q38541945-4FFC6F66-8486-4E02-91F0-D9351B0187E2Q38635488-5D55C4BC-2E2C-4393-8F03-0AABF57C7C11Q38744960-B11678CF-02AA-4457-AD51-513D37AED143
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Fausto Pinto
@ast
Fausto Pinto
@en
Fausto Pinto
@es
Fausto Pinto
@nl
Fausto Pinto
@sl
type
label
Fausto Pinto
@ast
Fausto Pinto
@en
Fausto Pinto
@es
Fausto Pinto
@nl
Fausto Pinto
@sl
altLabel
Fausto J Pinto
@en
prefLabel
Fausto Pinto
@ast
Fausto Pinto
@en
Fausto Pinto
@es
Fausto Pinto
@nl
Fausto Pinto
@sl
P1053
G-9363-2015
P106
P1153
7102740158
P21
P214
2307145857071722921311
P31
P3829
P496
0000-0002-8034-4529
P734
P735
P7859
lccn-n2016181682